Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 30
- Reported
- 28
- Verified
- 25
- Gap
- +5
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Strong
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Wait for stronger evidence
- Why
- Striking mechanistic signal (sub-48h cold-to-hot shift) and a Nature Biomedical Engineering follow-up, but the human dataset is n=4 feasibility-only; vendor and NCI both flag it as very early. Cross-domain interest in the mRNA/LNP platform is high but clinical readiness is low.
- Next
- Track UF's expanded Phase I (up to 24 adult/pediatric patients, then ~25 children Phase 2 via the pediatric consortium) for first human safety + survival readouts before treating as a maturing modality. Note NCT07306299 is a SEPARATE Zhejiang University universal-mRNA glioma trial, not UF's.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 7
- Tier 1
- 0
- Tier 2
- 1
- Tier 3
- 6
- Supports
- 2
- Contradicts
- 2
- Context
- 3
- Latest observed
- 2025-12-01
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.